These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1889708

  • 1. Concentration in pancreatic juice of lithostathine.
    Sarles H.
    Gastroenterology; 1991 Oct; 101(4):1139-40. PubMed ID: 1889708
    [No Abstract] [Full Text] [Related]

  • 2. Current status of pancreatic stone protein.
    Hayakawa T, Naruse S, Kitagawa M, Nakae Y, Hayakawa S.
    Nagoya J Med Sci; 1994 Dec; 57(3-4):109-18. PubMed ID: 7898566
    [Abstract] [Full Text] [Related]

  • 3. Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography.
    Mariani A, Mezzi G, Malesci A.
    Gut; 1995 Apr; 36(4):622-9. PubMed ID: 7737574
    [Abstract] [Full Text] [Related]

  • 4. Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
    Bimmler D, Graf R, Frick T.
    Pancreas; 1999 May; 18(4):417-8. PubMed ID: 10231850
    [No Abstract] [Full Text] [Related]

  • 5. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.
    Iovanna J, Frigerio JM, Dusetti N, Ramare F, Raibaud P, Dagorn JC.
    Pancreas; 1993 Sep; 8(5):597-601. PubMed ID: 8302796
    [Abstract] [Full Text] [Related]

  • 6. Quantification of human lithostathine S2-5 forms using the antibody to the N-terminal peptide region.
    Yamadera K, Wada K, Goto M, Yokoyama K, Morita Y, Kitano Y, Makino I.
    Pancreas; 1998 May; 16(4):475-80. PubMed ID: 9598807
    [Abstract] [Full Text] [Related]

  • 7. Human pancreatic reg protein immunoenzymatic assay and molecular form in serum.
    Carrère J, Guy-Crotte O, Figarella C.
    Clin Chim Acta; 1998 May 25; 273(2):185-94. PubMed ID: 9657348
    [Abstract] [Full Text] [Related]

  • 8. Quantification of human lithostathine by high performance liquid chromatography.
    Bernard JP, Barthet M, Gharib B, Michel R, Lilova A, Sahel J, Dagorn JC, De Reggi M.
    Gut; 1995 Apr 25; 36(4):630-6. PubMed ID: 7737575
    [Abstract] [Full Text] [Related]

  • 9. Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders.
    Schmiegel W, Burchert M, Kalthoff H, Roeder C, Bützow G, Grimm H, Kremer B, Soehendra N, Schreiber HW, Thiele HG.
    Gastroenterology; 1990 Nov 25; 99(5):1421-30. PubMed ID: 1698685
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
    Bimmler D, Graf R, Scheele GA, Frick TW.
    J Biol Chem; 1997 Jan 31; 272(5):3073-82. PubMed ID: 9006958
    [Abstract] [Full Text] [Related]

  • 11. Enzyme immunoassay for specific analysis of pancreatic stone proteins in human pancreatic juice.
    Katsuzaki T, Tatemichi N, Takeichi C, Hayakawa S, Hayakawa T, Shibata T, Harada H, Ochi K.
    J Clin Lab Anal; 1992 Jan 31; 6(6):375-8. PubMed ID: 1432363
    [Abstract] [Full Text] [Related]

  • 12. Protein inhibitors of calcium salt crystal growth in saliva, bile and pancreatic juice.
    Verdier JM, Dussol B, Berland Y, Dagorn JC.
    Scanning Microsc; 1993 Sep 31; 7(3):1017-30. PubMed ID: 8146603
    [Abstract] [Full Text] [Related]

  • 13. Renaming pancreatic stone protein as 'lithostathine'.
    Sarles H, Dagorn JC, Giorgi D, Bernard JP.
    Gastroenterology; 1990 Sep 31; 99(3):900-1. PubMed ID: 2379794
    [No Abstract] [Full Text] [Related]

  • 14. Why do pancreatic stents become occluded?
    Devière J.
    Gastrointest Endosc; 2005 Jun 31; 61(7):867-8. PubMed ID: 15933689
    [No Abstract] [Full Text] [Related]

  • 15. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals.
    De Reggi M, Gharib B, Patard L, Stoven V.
    J Biol Chem; 1998 Feb 27; 273(9):4967-71. PubMed ID: 9478942
    [Abstract] [Full Text] [Related]

  • 16. Crystallization and preliminary crystallographic study of human lithostathine.
    Pignol D, Bertrand JA, Bernard JP, Verdier JM, Dagorn JC, Fontecilla-Camps JC.
    Proteins; 1995 Dec 27; 23(4):604-6. PubMed ID: 8749859
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice.
    Multigner L, De Caro A, Lombardo D, Campese D, Sarles H.
    Biochem Biophys Res Commun; 1983 Jan 14; 110(1):69-74. PubMed ID: 6838525
    [No Abstract] [Full Text] [Related]

  • 18. Protein X, a proteolysis product of human pancreatic juice. Immunological relationship with trypsinogen 1.
    Amouric M, Barthe C, Kopeyan C, Figarella C, Guy-Crotte O.
    Biol Chem Hoppe Seyler; 1987 Nov 14; 368(11):1525-32. PubMed ID: 3124868
    [Abstract] [Full Text] [Related]

  • 19. The disulfide bridges of the immunoreactive forms of human pancreatic stone protein isolated from pancreatic juice.
    Rouimi P, de Caro J, Bonicel J, Rovery M, de Caro A.
    FEBS Lett; 1988 Feb 29; 229(1):171-4. PubMed ID: 3345835
    [Abstract] [Full Text] [Related]

  • 20. What function for human lithostathine?: structural investigations by three-dimensional structure modeling and high-resolution NMR spectroscopy.
    Patard L, Stoven V, Gharib B, Bontems F, Lallemand JY, De Reggi M.
    Protein Eng; 1996 Nov 29; 9(11):949-57. PubMed ID: 8961348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.